Clinic Versus Home Spirometry

N/AUnknownNCT05219773

University of Nottingham68 enrolled

Overview

The study aims to assess the differences between spirometry performed with the NuvoAir Air Next spirometer in the clinic setting with both direct and virtual supervision via a video call, and in the home setting with virtual supervision. This is will be achieved by comparing lung function values, specifically the FEV1 and FVC measurements. We also wish to evaluate participant's perceptions of home spirometry, by using a survey. This is a multi-centre, cross-over study. The study will enrol participants with a diagnosis of asthma and COPD, across participating study sites until 68 have completed the study.

Study Type

INTERVENTIONAL

Allocation

Purpose

OTHER

Masking

NONE

Enrollment

Conditions

Asthma Chronic Obstructive Pulmonary Disease

Interventions

NuvoAir Air Next spirometerDEVICE

* The collection of medical history and demographic data * Spirometry testing in both the clinic and home setting. * The measurement of height and weight. * The evaluation of the perception of home spirometry via a survey.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * An ability to provide fully informed consent. * A diagnosis of asthma or COPD. * Male or female aged ≥18 and ≤ 80 years of age. Exclusion Criteria: * Symptoms suggestive of COVID-19. * An exacerbation of asthma or COPD or symptoms of a respiratory infection within the 30 days prior to the first visit. * Any other clinically significant medical disease or uncontrolled concomitant disease, that is likely, in the opinion of the Investigator(s), to impact on the ability to participate in the study. * The presence of any contraindications to spirometry.

Locations (3)

Respiratory Research Unit

Nottingham, Nottinghamshire, United Kingdom

RECRUITING

Bradford Teaching Hospitals NHS Foundation Trust

Bradford, United Kingdom

NOT_YET_RECRUITING

The Rotherham NHS Foundation Trust

Rotherham, United Kingdom

NOT_YET_RECRUITING

Outcomes

Primary Outcomes

1. To compare spirometric values obtained from the NuvoAir Air Next device, directly supervised in clinic and virtually supervised in clinic and at home.

Over an 8-day period; the forced expiratory volume in 1 second (FEV1) and forced vital Capacity (FVC) will be measured at 4 points in the study over the 8 day study period. Twice in clinic and twice at home.

Time frame: 8 days

2. To compare spirometric values obtained from two virtually supervised tests performed at home, using the NuvoAir Air Next device.

The forced expiratory volume in 1 second (FEV1) and forced vital Capacity (FVC) will be measured via the NuvoAir Air Next spirometer at home at 2 points during the 8 day study period.

Time frame: 8 days

Secondary Outcomes

To evaluate the participant's views of home spirometry via a survey.

A standardised survey to evaluate the participant's perception of home spirometry, will be performed.

Time frame: 8 days

Central Contacts

Ashish Pradhan

CONTACT

07816 097200 ashish.pradhan@nottingham.ac.uk

Nicola Neesham

CONTACT

07816 097200 nicola.neesham@nuh.nhs.uk

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.